renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 360ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 60ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 120ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 240ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 360ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
renu multiplus multi-purposesolution combination
al jaber trading agencies llc italy - 60ml bottle - solution - combination - eye-contact lenses, eye-miscellaneous
nano 999999
nanoplus limited (cayman) taiwan branch - hydroxide ion (unii: 9159uv381p) (hydroxide ion - unii:9159uv381p) -
fibrovein 1.0% sodium tetradecyl sulfate 20mg/2ml injection ampoule
intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 10 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.
fibrovein 0.2% sodium tetradecyl sulfate 10mg/5ml multidose injection vial
intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 2 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.
fibrovein 3% sodium tetradecyl sulfate 30mg/1ml multidose injection vial
australasian medical & scientific ltd - sodium tetradecyl sulfate, quantity: 30 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; water for injections; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; sodium hydroxide - indications as at 09 june 2005 : the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give rise to adverse reactions.